Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis

B-Chronic Lymphocytic Leukemia (CLL) is an incurable disease predominantly characterized by apoptosis resistance. We have previously described a VEGF signaling pathway that generates apoptosis resistance in CLL B cells. We found induction of significantly more apoptosis in CLL B cells by co-culture with an anti-VEGF antibody. To increase the efficacy of these agents in CLL therapy we have focused on the use of gold nanoparticles (GNP). Gold nanoparticles were chosen based on their biocompatibility, very high surface area, ease of characterization and surface functionalization. We attached VEGF antibody (AbVF) to the gold nanoparticles and determined their ability to kill CLL B cells. Gold nanoparticles and their nanoconjugates were characterized using UV-Visible spectroscopy (UV-Vis), transmission electron microscopy (TEM), thermogravimetric analysis (TGA) and X-ray photoelectron spectroscopy (XPS). All the patient samples studied (N = 7) responded to the gold-AbVF treatment with a dose dependent apoptosis of CLL B cells. The induction of apoptosis with gold-AbVF was significantly higher than the CLL cells exposed to only AbVF or GNP. The gold-AbVF treated cells showed significant down regulation of anti-apoptotic proteins and exhibited PARP cleavage. Gold-AbVF treated and GNP treated cells showed internalization of the nanoparticles in early and late endosomes and in multivesicular bodies. Non-coated gold nanoparticles alone were able to induce some levels of apoptosis in CLL B cells. This paper opens up new opportunities in the treatment of CLL-B using gold nanoparticles and integrates nanoscience with therapy in CLL. In future, potential opportunities exist to harness the optoelectronic properties of gold nanoparticles in the treatment of CLL.

[1]  Xiaohua Huang,et al.  Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. , 2006, Cancer letters.

[2]  M Geso,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2007, The British journal of radiology.

[3]  Xiaohua Huang,et al.  Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. , 2005, Nano letters.

[4]  Vincent M Rotello,et al.  Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. , 2004, Bioconjugate chemistry.

[5]  G. Whitesides,et al.  Self-assembled monolayers of thiolates on metals as a form of nanotechnology. , 2005, Chemical reviews.

[6]  M. Dierich,et al.  Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21). , 2000, Blood.

[7]  R. Bruce Lennox,et al.  Gold−Sulfur Bonding in 2D and 3D Self-Assembled Monolayers: XPS Characterization , 2000 .

[8]  J. Folkman,et al.  Angiogenesis and apoptosis. , 2003, Seminars in cancer biology.

[9]  George M. Whitesides,et al.  Formation of monolayers by the coadsorption of thiols on gold: variation in the head group, tail group, and solvent , 1989 .

[10]  T. Kojima,et al.  Antitumor effect of gold as revealed by growth suppression of cultured cancer cells. , 1998, Cancer biotherapy & radiopharmaceuticals.

[11]  Xunbin Wei,et al.  Selective cell targeting with light-absorbing microparticles and nanoparticles. , 2003, Biophysical journal.

[12]  M. Grever,et al.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[13]  T. Shanafelt,et al.  The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. , 2006, Seminars in oncology.

[14]  R. Stafford,et al.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Faulk,et al.  Communication to the editors: An immunocolloid method for the electron microscope , 1971 .

[16]  D. Mukhopadhyay,et al.  Gold Nanoparticles Bearing Functional Anti-Cancer Drug and Anti-Angiogenic Agent: A "2 in 1" System with Potential Application in Cancer Therapeutics , 2005 .

[17]  S. Soker,et al.  In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. , 2002, Blood.

[18]  H. Sheardown,et al.  Cell adhesion peptide modification of gold-coated polyurethanes for vascular endothelial cell adhesion. , 2001, Journal of biomedical materials research.

[19]  R M Albrecht,et al.  Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.

[20]  H. Goldschmidt,et al.  Angiogenesis in hematologic malignancies , 2001, Annals of Hematology.

[21]  S. Vohora,et al.  Analgesic activity of gold preparations used in Ayurveda & Unani-Tibb. , 1998, The Indian journal of medical research.

[22]  T. Shanafelt,et al.  VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance , 2005, Leukemia.

[23]  Anthony Atala,et al.  Gold Nanoparticles Inhibit VEGF165-Induced Proliferation of HUVEC Cells , 2004 .

[24]  A. Ulman,et al.  Alkanethiol molecules containing an aromatic moiety self-assembled onto gold clusters , 1997 .

[25]  Ling Wang,et al.  Antiangiogenic Properties of Gold Nanoparticles , 2005, Clinical Cancer Research.

[26]  R. Kumar,et al.  Size discrimination of colloidal nanoparticles by thiol-functionalized MCM-41 mesoporous molecular sieves , 2000 .

[27]  T. Shanafelt,et al.  VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. , 2004, Blood.

[28]  B. Cheson,et al.  Monoclonal antibody therapy of chronic lymphocytic leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  R. Kumar,et al.  Amphoterization of colloidal gold particles by capping with valine molecules and their phase transfer from water to toluene by electrostatic coordination with fatty amine molecules , 2000 .

[30]  W. Faulk,et al.  An immunocolloid method for the electron microscope. , 1971, Immunochemistry.

[31]  D. Mukhopadhyay,et al.  Gold Nanoparticles do not Affect the Global Transcriptional Program of Human Umbilical Vein Endothelial Cells: A DNA-Microarray Analysis , 2005 .

[32]  D. Astruc,et al.  Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. , 2004, Chemical reviews.

[33]  E. Sausville,et al.  Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine. , 2004, Blood.

[34]  N. Kay.  The angiogenic status of B-CLL B cells: role of the VEGF receptors. , 2004, Leukemia research.

[35]  A. List.  Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. , 2001, The oncologist.

[36]  B. Cheson.  Monoclonal antibody therapy of chronic lymphocytic leukemia , 2006, Cancer Immunology, Immunotherapy.

[37]  Ludovic Jullien,et al.  Synthesis and properties of water-soluble gold colloids covalently derivatized with neutral polymer monolayers. , 2002, Journal of the American Chemical Society.

[38]  J. Minna,et al.  Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. , 2000, Cancer research.